Talavera EM, Zafra MF, Gil-Villarino A, Prez M.I, Alvarez JM, Garca-Pelegrin F
What to Expect: The Good, the Bad, and the Honest GLP-1 medications are powerful, but theyre not magic
Funding This work was supported by the Henan Provincial Breast Cancer Precision Prevention and Control Engineering Research Center (ZC20220050), the Henan Provincial Peoples Hospital23456 Talent Engineering Project (ZC23456026) and the study on the Effect and Mechanism of Macrophage-Derived Exosomes Loaded with Doxorubicin for Targeted Therapy of Triple-Negative Breast Cancer (ZC20220114)
tirzepatide works on a second hormone pathway as well, and some patients respond to it better
Acute pancreatitis: Cases reported in patients using GLP-1 medications
The final reduction and discontinuation The transition from 2.5 mg to zero is psychologically the hardest step, even though the pharmacological difference is relatively small